Dr. Chong Yin | Medicine | Best Researcher Award

Dr. Chong Yin | Medicine | Best Researcher Award

Dr. Chong Yin | Associate Researcher | Affiliated Hospital of North Sichuan Medical College | China

Academic Background

Chong Yin holds a comprehensive academic background in biotechnology, animal genetics, and biomedical engineering, progressing from a Bachelor of Science degree in Biotechnology to a Ph.D. in Biomedical Engineering. His educational foundation has equipped him with a strong interdisciplinary understanding of molecular biology, genetic research, and biomedical applications. His work has been widely recognized and cited across multiple scientific platforms, with over fifteen hundred citations by more than thirteen hundred documents. His research output spans over fifty documents, reflecting a significant and sustained contribution to the field. With an h-index of twenty-two, as recorded on Scopus and Google Scholar, his influence in osteogenic and molecular biology research continues to grow.

Research Focus

Chong Yin’s research focuses on the molecular mechanisms governing bone biology, particularly osteoporosis, and the development of nucleic acid-based therapeutics. His work integrates phase separation, gene editing, and hydrogel technologies to explore novel strategies for enhancing bone regeneration and repair. He aims to bridge fundamental cellular biology with translational therapies for skeletal diseases, focusing on innovative approaches for osteogenic differentiation and bone metabolism.

Work Experience

Chong Yin began his professional career as a graduate assistant at the University of Mississippi Medical Center, where he contributed to foundational biomedical research. He then undertook postdoctoral research at Northwestern Polytechnical University, further refining his expertise in cellular and molecular biology. He currently serves as an Associate Researcher and Associate Professor at the Affiliated Hospital of North Sichuan Medical College, where he leads multiple research initiatives in bone biology and regenerative medicine.

Key Contributions

Chong Yin has made substantial contributions to understanding osteoblast differentiation, bone formation, and mechanotransduction in skeletal tissues. He has pioneered studies on long noncoding RNAs and microRNAs that regulate bone metabolism and developed biomimetic hydrogels with applications in osteomyelitis treatment. His work has provided valuable insights into the biomechanical mechanisms underlying bone remodeling and the therapeutic potential of RNA-based and hydrogel-mediated interventions.

Awards & Recognition

Chong Yin’s contributions have been recognized with prestigious national and international awards, including grants for young investigators and accolades for innovative research in skeletal disease treatment. His work has garnered recognition for advancing translational approaches in bone biology and regenerative medicine.

Professional Roles & Memberships

He is an active member of multiple scientific societies, including the International Chinese Musculoskeletal Research Society, the Chinese Society of Cell Biology, and the Chinese Anti-cancer Association. He serves as a young editorial member for journals such as iMeta and Burns & Trauma, reflecting his growing influence in scientific publishing and peer review.

Profile

Scopus

Featured Publications

Yin, C., Tian, Y., Yu, Y., et al. Long noncoding RNA AK039312 and AK079370 inhibits bone formation via miR-199b-5p. Pharmacol Res.

Yin, C., Tian, Y., Li, D., et al. Long non-coding RNA Lnc-DIF inhibits bone formation by sequestering miR-489-3p. Iscience.

Hu, L., Yin, C., Chen, D., et al. MACF1 promotes osteoblast differentiation by sequestering repressors in cytoplasm. Cell Death Differ.

Tian, Y., Zhao, Y., Yin, C., et al. Polyvinylamine with moderate binding affinity as a highly effective vehicle for RNA delivery. J Control Release.

Yin, C., Zhang, Y., Hu, L., et al. Mechanical unloading reduces microtubule actin crosslinking factor 1 expression to inhibit β-catenin signaling and osteoblast proliferation. J Cell Physiol.

Impact Statement / Vision

Chong Yin envisions advancing the field of bone biology by translating molecular insights into practical therapies that improve patient outcomes. His research aims to integrate genetic, biochemical, and biomaterial strategies to address skeletal disorders and enhance regenerative medicine approaches, establishing a framework for innovative and clinically relevant treatments.

Jayalakshmi Mariakuttikan | Medicine | Best Researcher Award

Dr. Jayalakshmi Mariakuttikan | Medicine | Best Researcher Award

Dr. Jayalakshmi Mariakuttikan , Associate Professor , Madurai Kamaraj University , India.

Dr. M. Jayalakshmi, Ph.D., is a distinguished Associate Professor and Head of the Department of Immunology at the School of Biological Sciences, Madurai Kamaraj University, Tamil Nadu. Since 2005, she has dedicated her research to immunogenetics, focusing on disease susceptibility in South Indian populations. With postdoctoral training from UCSF, USA, and a prolific academic journey, she has mentored numerous scholars and spearheaded advanced research projects. She has delivered over 110 invited talks, published 40+ international papers, and contributed to impactful policy research. Her commitment to immunology and education underscores her stature as a respected academician and researcher in biomedical science.

Publication Profile

Scopus

Google Scholar

🎓 Education Background

Dr. Jayalakshmi earned her Ph.D. in Immunogenetics from Manonmaniam Sundaranar University, conducting her doctoral research at Holy Cross College, Nagercoil. She ranked first in her B.Sc. and M.Sc. (Zoology) programs from the same university, showcasing academic excellence early on. Her M.Phil. at St. Xavier’s College, Palayamkottai, also saw her secure the top rank. She further enhanced her expertise through a prestigious Raman Postdoctoral Fellowship at the University of California, San Francisco (UCSF), focusing on transplantation immunogenetics. Her strong academic foundation and exposure to global research platforms empower her ongoing scientific contributions in immunogenetics and molecular diagnostics.

🧪 Professional Experience

Dr. M. Jayalakshmi began her career as an Assistant Professor in 2005 at Madurai Kamaraj University and has served as Associate Professor and Head since 2017. Her academic leadership includes coordinating molecular diagnostic training, spearheading RUSA-funded research facilities, and serving as a syndicate member at MKU. She has also mentored numerous M.Sc. and Ph.D. students. With experience spanning teaching, research, and administration, she has organized skill development programs benefiting over 1,100 students. Additionally, she plays key roles in academic boards, ethics committees, and national curriculum development, consistently contributing to life science education and translational biomedical research.

🏅 Awards and Honors

Dr. Jayalakshmi’s academic brilliance has earned her multiple prestigious awards. She was a gold medalist and university topper in both B.Sc. and M.Sc. Zoology programs. She received the National Merit Scholarship and CSIR Fellowships during her Ph.D. journey. Her innovative teaching earned her the Gold Medal from Madurai Kamaraj University. She was awarded the UGC-Raman Postdoctoral Fellowship for her research at UCSF, USA, and has served as a DST-INSPIRE Mentor since 2008. Her scholarly contributions include 16 best paper awards at international conferences, reflecting her impactful presence in global immunogenetics research and scientific communication.

🔬 Research Focus

Dr. Jayalakshmi’s research centers on the immunogenetics of breast cancer, autoimmune disorders (Type 1 Diabetes, RHD), infectious diseases (HIV, HBV), and chronic kidney disease. Since 2005, she has analyzed the South Indian population’s genetic profiles using advanced tools like PCR and Next-Generation Sequencing. Her studies aim to identify genetic susceptibility markers and early diagnostic tools, contributing significantly to personalized medicine. Her lab has also explored microbiomes and HLA allele associations through funded research projects. With over 120 gene sequences and 14 whole-genome submissions to NCBI, her team’s research outcomes have international implications in immunogenomics and translational diagnostics.

🧭 Conclusion

Dr. M. Jayalakshmi exemplifies excellence in education, research, and scientific leadership in immunogenetics. Her pioneering work across cancer, infectious diseases, and autoimmune disorders in South India has advanced diagnostic research and molecular epidemiology. With a global research footprint, numerous scholarly contributions, and unwavering dedication to mentorship and innovation, she continues to inspire students and scientists alike. Through her active role in academic councils and ethical boards, she advocates for responsible science and societal health impact. Her career is a testament to the transformative power of science driven by curiosity, precision, and community engagement.

📚 Top Publication Notes

  1. Impact of unique host genetic variants in the HIV life cycle
    Human Gene (2025) — Differentiates HIV progression among South Indian females.
    Cited by: 5 articles

  2. Genomic Diversity and Antimicrobial Resistance of Acinetobacter sp.
    Indian Journal of Microbiology (2024) — Explores pan-genome and resistance markers.
    Cited by: 2 articles

  3. Association of Vitamin D receptor polymorphisms with Type 1 diabetes
    Journal of Clinical Research in Pediatric Endocrinology (2024) — Highlights VDR polymorphism link to T1D.
    Cited by: 3 articles

  4. The microbiome and rheumatic heart disease
    Acta Cardiologica (2023) — Discusses microbial links to RHD pathogenesis.
    Cited by: 1 article

  5. KIR-HLA ligand association with Type 1 Diabetes
    Immunological Investigations (2023) — Investigates KIR gene role in autoimmune risk.
    Cited by: 4 articles

  6. HLA-DRB1 Alleles with Rheumatic Heart Disease
    Immunological Investigations (2022) — Meta-analysis connecting HLA variants and RHD.
    Cited by: 6 articles

  7. HLA-G 3’UTR polymorphism and breast cancer
    Journal of Clinical Pathology (2020) — Links HLA-G variant with breast cancer susceptibility.
    Cited by: 12 articles

 

Prof. Dr. Vicente Vanaclocha | Medicine | Lifetime achievement Award

Prof. Dr. Vicente Vanaclocha | Medicine | Lifetime achievement Award

Full Professor, University of Valencia, Spain

Dr. Vicente Vanaclocha-Vanaclocha  is a renowned Spanish neurosurgeon with over four decades of clinical and academic experience. Recognized for his dedication to advancing neurosurgical techniques, he serves as a Consultant Neurosurgeon at Consorcio Hospital General Universitario de Valencia and a Professor of Neurosurgery at the University of Valencia. Known for his work in spine surgery, brain tumors, and peripheral nerves, he remains an influential figure in both national and international neurosurgical communities.

Publication Profile

🎓 Education Background:

Dr. Vanaclocha began his medical journey at the School of Medicine, Universidad de Valencia (1977–1982), earning his MD degree. He completed his neurosurgery specialization at Hospital Clínico Universitario de Valencia (1983–1987) and pursued a PhD in Neurosurgery from Universidad de Valencia, awarded in 1988. In addition to his medical training, he holds advanced language qualifications: C1 German from Goethe Institut, C1 English from the University of Cambridge, and C2 Català from Junta Qualificadora de Coneiximents de Valencia.

💼 Professional Experience:

His illustrious career includes leadership roles such as Head of Neurosurgery at Clinica Universidad de Navarra (1989–1999) and Consorcio Hospital General Universitario de Valencia (2011–2015). He has also practiced at international institutions, including Groote Schuur Hospital in South Africa (1988–1989), enriching his global neurosurgical perspective. He continues to work in private practice at Hospital Vithas Valencia 9 de Octubre and has previous experience in other prominent hospitals across Spain.

🏅 Awards and Honors:

Dr. Vanaclocha is a respected member of prestigious professional societies, including the American Association of Neurological Surgeons (AANS) since 2017, North American Spine Society (NASS) since 2009, European Association of Neurosurgical Societies (EANS) since 1989, and Sociedad Española de Neurocirugía (SENEC) since 1987. His extensive memberships reflect international recognition of his professional contributions.

🔬 Research Focus:

His research interests span neurosurgery with a specific focus on sacroiliac joint pain, spinal biomechanics, peripheral nerve regeneration, and brain tumor treatment. His recent studies emphasize innovations in implant design, spinal motion preservation, and cerebrospinal fluid management in hemorrhagic conditions.

📝 Conclusion:

Dr. Vicente Vanaclocha-Vanaclocha is a pioneering figure in neurosurgery, blending clinical expertise with innovative research and multilingual communication skills. His impact on spinal surgery and neurotrauma continues to shape both academic inquiry and practical medicine in Europe and beyond.

📚 Top Publications:

Effect of Ti6Al4V Alloy Surface and Porosity on Bone Osseointegration: In Vivo Pilot Study in Rabbits
Materials, 2025
 Cited by: Articles on Crossref (citation data pending as it’s recently published)

Dental Implant with Porous Structure and Anchorage: Design and Bench Testing in a Calf Rib Model Study
Materials, 2025
 Cited by: Articles on Crossref (citation data pending)

New Subperiosteal Dental Implant Design with Finite Element Analysis and Mechanical Validation: A Design Validation Study
Materials, 2025
Cited by: Articles on Crossref (citation data pending)

Can a single basal cistern urokinase bolus help to prevent subarachnoid hemorrhage consequences?
Heliyon, 2024
 Cited by: Articles on Crossref (citation data pending)

Prevertebral Anchored Kevlar Band to Recover Intact Spine Movement Ranges in Lumbar Disc Arthroplasty
Biomedical Materials & Devices, 2024
 Cited by: Articles on SpringerLink (citation data pending)